The TXNIP–mTOR–Autophagy axis in diabetic kidney disease: mechanistic insights and therapeutic implications
Authors:
- 21 August 2025
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-13
Abstract
Diabetic kidney disease (DKD) remains a prevalent complication of diabetes mellitus and a leading cause of end-stage renal disease. A growing body of evidence highlights the central role of the thioredoxin-interacting protein (TXNIP)–mTOR–autophagy axis in the pathogenesis of DKD. Chronic hyperglycemia significantly induces TXNIP expression, triggering oxidative stress, inflammasome activation, and mitochondrial dysfunction in renal cells. TXNIP directly promotes activation of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1), which consequently impairs autophagic flux, leading to accumulation of damaged organelles and proteins, cellular hypertrophy, and fibrosis. Restoration of autophagy via inhibition of TXNIP or mTOR signaling pathways alleviates these pathological changes in various DKD models. Specifically, genetic or pharmacological suppression of TXNIP attenuates oxidative injury, reduces inflammasome activation, and restores autophagic activity. Similarly, mTOR inhibitors such as rapamycin have demonstrated substantial renoprotective effects through reactivation of autophagy and reduction of renal fibrosis. Furthermore, combined targeting of TXNIP and mTOR presents a promising therapeutic strategy that may synergistically restore autophagic homeostasis with reduced side effects. This review synthesizes recent mechanistic insights into the interplay between TXNIP, mTOR signaling, and autophagy dysregulation in DKD and discusses potential therapeutic interventions. Ultimately, understanding and therapeutically targeting the TXNIP–mTOR–autophagy axis could offer new opportunities for effective clinical management of diabetic kidney disease.Keywords
This publication has 84 references indexed in Scilit:
- Xanthohumol attenuates TXNIP-mediated renal tubular injury in vitro and in vivo diabetic modelsJournal of Natural Medicines, 2025
- The thioredoxin system: Balancing redox responses in immune cells and tumorsEuropean Journal of Immunology, 2022
- Thioredoxin-interacting protein: a critical link between autophagy disorders and pancreatic β-cell dysfunctionEndocrine, 2020
- Silencing of TXNIP Alleviated Oxidative Stress Injury by Regulating MAPK–Nrf2 Axis in Ischemic StrokeNeurochemical Research, 2019
- Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetesDiabetologia, 2017
- Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potentialCellular and Molecular Life Sciences, 2017
- Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocyclineInflammation Research, 2016
- Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic miceMolecular and Cellular Biochemistry, 2014
- Mutagenic analysis in a pure molecular system shows that thioredoxin‐interacting protein residue Cys247 is necessary and sufficient for a mixed disulfide formation with thioredoxinProtein Science, 2012
- Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditionsJournal of Cellular Physiology, 2009